National Institute of Environmental Health Sciences
(NIEHS) Superfund Research Program (SRP) grantees and in-house scientists are lending their expertise in data integration and online tool development to explore how COVID-19 spreads and why some communities experience higher risk of infection. The projects described below represent just some of the diverse research underway at SRP centers during the COVID-19 pandemic.
Full article here
Illumina received an emergency authorization from the FDA for its COVID-19 test designed to sequence the full genome of the novel coronavirus.
Using the company's high-throughput NovaSeq 6000 hardware, the diagnostic COVIDSeq Test is capable of processing over 3,000 samples at once, taken from nasopharyngeal and oropharyngeal swabs. Results are provided within 24 hours.
"COVIDSeq leverages the performance of [next-generation sequencing] to help address the global need for diagnostic testing to fight the COVID-19 pandemic," Illumina CEO Francis deSouza said in a